Reuters - Women who carry a faulty copy of a gene called RAD51D have an almost one in 11 chance of developing ovarian cancer, scientists said on Sunday in a finding they called the most significant ovarian cancer gene discovery for more than 10 years. us.rd.yahoo.com
...Read On
Medical researchers have shown for the first time that engineered human T cells can eradicate deadly human ovarian cancer in immune-deficient mice. www.sciencedaily.com
...Read On
Medical researchers have shown for the first time that engineered human T cells can eradicate deadly human ovarian cancer in immune-deficient mice. www.sciencedaily.com
...Read On
In a recent issue of Cancer Research, Daniel J. Powell, Jr., PhD, a research assistant professor of Pathology and Laboratory Medicine and Obstetrics and Gynecology at the Perelman School of Medicine at the University of Pennsylvania, showed for the first time that engineered human T cells can eradicate deadly human ovarian cancer in immune-deficient mice. Ovarian cancer is the most lethal reproductive cancer for women, with one-fifth of women diagnosed with advanced disease surviving five years. Nearly all ovarian cancers (90%) are characterized by their expression of a distinct cell-surface protein called alpha-folate receptor, which can be a target for engineered T cells. www.physorg.com
...Read On
A team of German and Italian EU-funded scientists has designed peptides that can target the protein-protein interface of an enzyme that plays a key part in the DNA synthesis crucial for cancer growth. www.physorg.com
...Read On
You can link to this article on your web site using following code:
Website Code:
Forum Code:
Comments
We're looking for comments that are interesting, substantial or highly amusing. If your comments are excessively self-promotional (use your real name, no keywords please), obnoxious, or even worse, boring, you will be banned from commenting. Your comment must be related to the post. Please do not comment on how great or wonderful the post is. All comments are moderated and, if approved, will display in less than 24 hours.
